Literature DB >> 27788386

Roles of OCT4 in tumorigenesis, cancer therapy resistance and prognosis.

Emilly Schlee Villodre1, Franciele Cristina Kipper2, Mariana Brutschin Pereira3, Guido Lenz4.   

Abstract

OCT4 (POU5F1) is a major regulator of cell pluripotency and plays an important role not only during embryogenesis but also in tumorigenesis. It has been studied in various types of cancers, since stemness is an important factor for cancer growth and therapy. Here we present basic information about the OCT4 gene, its isoforms and pseudogenes besides discussing the current literature in which OCT4 is linked to cancer, emphasizing its roles in tumorigenesis and therapy. The majority of studies indicated a negative correlation between the expression of OCT4 and prognosis, and only in testicular germ cell tumor this correlation was positive. Using The Cancer Genome Atlas database we showed that OCT4 expression correlated negatively with patient survival in pancreatic cancer. All those different impacts of OCT4 on cancer indicate the biological complexity of this transcription factor in biology and, therefore, also in cancer. Copyright Â
© 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cancer biomarker; Cancer stem cell; Chemoresistance; OCT4; POU5F1; Prognosis

Mesh:

Substances:

Year:  2016        PMID: 27788386     DOI: 10.1016/j.ctrv.2016.10.003

Source DB:  PubMed          Journal:  Cancer Treat Rev        ISSN: 0305-7372            Impact factor:   12.111


  40 in total

1.  Silencing the OCT4-PG1 pseudogene reduces OCT-4 protein levels and changes characteristics of the multidrug resistance phenotype in chronic myeloid leukemia.

Authors:  Aline Portantiolo Lettnin; Eduardo Felipe Wagner; Michele Carrett-Dias; Karina Dos Santos Machado; Adriano Werhli; Andrés Delgado Cañedo; Gilma Santos Trindade; Ana Paula de Souza Votto
Journal:  Mol Biol Rep       Date:  2019-02-05       Impact factor: 2.316

2.  TGIF2 promotes the progression of lung adenocarcinoma by bridging EGFR/RAS/ERK signaling to cancer cell stemness.

Authors:  Renle Du; Wenzhi Shen; Yi Liu; Wenjuan Gao; Wei Zhou; Jun Li; Shuangtao Zhao; Chong Chen; Yanan Chen; Yanhua Liu; Peiqing Sun; Rong Xiang; Yi Shi; Yunping Luo
Journal:  Signal Transduct Target Ther       Date:  2019-12-13

3.  The Dark Side of Gefitinib: Reflectance Confocal Microscopy Applied to Hair Hyperpigmentation.

Authors:  Terenzio Cosio; Sara Mazzilli; Luca Bianchi; Elena Campione
Journal:  Skin Appendage Disord       Date:  2019-10-25

Review 4.  Cellular functions of stem cell factors mediated by the ubiquitin-proteasome system.

Authors:  Jihye Choi; Kwang-Hyun Baek
Journal:  Cell Mol Life Sci       Date:  2018-02-08       Impact factor: 9.261

5.  Microarray-based Analysis of Genes, Transcription Factors, and Epigenetic Modifications in Lung Cancer Exposed to Nitric Oxide.

Authors:  Arnatchai Maiuthed; Ornjira Prakhongcheep; Pithi Chanvorachote
Journal:  Cancer Genomics Proteomics       Date:  2020 Jul-Aug       Impact factor: 4.069

6.  Nitric oxide promotes cancer cell dedifferentiation by disrupting an Oct4:caveolin-1 complex: A new regulatory mechanism for cancer stem cell formation.

Authors:  Arnatchai Maiuthed; Narumol Bhummaphan; Sudjit Luanpitpong; Apiwat Mutirangura; Chatchawit Aporntewan; Arthitaya Meeprasert; Thanyada Rungrotmongkol; Yon Rojanasakul; Pithi Chanvorachote
Journal:  J Biol Chem       Date:  2018-07-09       Impact factor: 5.157

7.  PHF20 collaborates with PARP1 to promote stemness and aggressiveness of neuroblastoma cells through activation of SOX2 and OCT4.

Authors:  Wenyong Long; Wei Zhao; Bo Ning; Jing Huang; Junjun Chu; Linfeng Li; Qianquan Ma; Changsheng Xing; Helen Y Wang; Qing Liu; Rong-Fu Wang
Journal:  J Mol Cell Biol       Date:  2018-04-01       Impact factor: 6.216

8.  Tex10 is upregulated and promotes cancer stem cell properties and chemoresistance in hepatocellular carcinoma.

Authors:  Xiaocong Xiang; Li Deng; Rong Xiong; Dongqin Xiao; Zhu Chen; Fei Yang; Kang Liu; Gang Feng
Journal:  Cell Cycle       Date:  2018-07-25       Impact factor: 4.534

9.  Expression of vimentin and Oct-4 in gallbladder adenocarcinoma and their relationship with vasculogenic mimicry and their clinical significance.

Authors:  Yu Zhang; Jing Xu; Zhouyi Xu; Yichao Wang; Shiwu Wu; Lu Wu; Hong Song; Lei Zhou
Journal:  Int J Clin Exp Pathol       Date:  2018-07-01

Review 10.  Markers of pancreatic cancer stem cells and their clinical and therapeutic implications.

Authors:  Arkadiusz Gzil; Izabela Zarębska; Wiktor Bursiewicz; Paulina Antosik; Dariusz Grzanka; Łukasz Szylberg
Journal:  Mol Biol Rep       Date:  2019-09-05       Impact factor: 2.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.